Target intelligence / Profile preview

RHEB pseudogene 3 (RHEBP3)

Target: RHEBP3
Molecular classification: Other (pseudogene)

Overview

RHEB pseudogene 3 (RHEBP3) is a processed pseudogene related to the RHEB gene. While RHEB is known as a member of the Ras superfamily of small GTPases and is implicated in cell cycle regulation via the mTOR pathway, RHEBP3 itself does not produce a functional protein and is not implicated in any biological process, disease mechanism, or as a drug target[1][3]. Several RHEB-related pseudogenes exist in the human genome, but current scientific consensus recognizes only the functional RHEB gene (not its pseudogenes) as significant in molecular biology and medicine[1][3]. RHEBP3 is not a canonical therapeutic target, and queries about it as a receptor or enzyme are based on a misunderstanding of its biological nature.

Mechanism of action

None

Beyond the preview

Go deeper on RHEB pseudogene 3 (RHEBP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RHEB pseudogene 3 (RHEBP3).

Explore the full profile